सोमवार, 27 मई 2019

thumbnail

Lupin slips 5% as USFDA classifies Goa facility's inspection as OAI

The USFDA stated that Goa facility may be subject to regulatory or administrative action and that it may withhold approval of any pending applications or supplements in which this facility is listed.

from Latest News http://bit.ly/2K3sM1v

Related Posts :

Subscribe by Email

Follow Updates Articles from This Blog via Email

No Comments

About

ब्लॉग आर्काइव

Blogger द्वारा संचालित.